Reason for Sale: Growing Nationally Into Full Commercialization- Patented & FDA Approved De-Risked Spinal Implant Manufacturing Company. Entity provides a unique platform into the $20B Global Spinal Implant Market. Flagship product has been released and is generating revenue. The entity has an additional pipeline of products encompassing 3D printing and nano-technology to round out their portfolio in development. The company product line offers a versatile implant system which offers spinal surgeons inter-operative options & reduces "fiddle factor" while providing patient benefits documented by a clinical white paper validating the technology. The platform was designed to create benefits across all segments, Surgeon, Facility and Patients. Complete executive summary available.
Information Not Provided
Provided by Owner:
Growing Nationally Into Full Commercialization.
following company and/or agent is a licensed real estate
broker/and or a business broker.